RadNet Inc (RDNT) Q1 2026 Earnings Call Transcript

Why It Matters

The results underscore RadNet’s accelerating shift toward high‑margin advanced imaging and AI‑driven digital health, positioning it as a leading provider in the rapidly expanding radiology AI market.

Key Takeaways

• Record $547.7M revenue, 14.8% year‑over‑year growth.
• Digital Health revenue jumps 48.2% to $27.9M.
• Gleamer acquisition adds $30M ARR, targets AI leadership.
• 2026 guidance: Imaging centers 17‑19% growth, Digital Health 45‑55%.
• Net debt‑to‑EBITDA stays near 1.0, cash $767M.

Pulse Analysis

The radiology industry continues its migration from hospital‑based services to freestanding imaging centers, a trend amplified by higher reimbursement for outpatient procedures and patient preference for convenience. RadNet’s record quarterly revenue reflects this shift, with advanced imaging modalities such as MRI, CT, and PET/CT now comprising nearly 30% of procedural volume. By expanding its footprint through de novo builds and strategic joint‑venture partnerships, the company is capturing a larger share of the growing demand for high‑complexity diagnostics, which command premium pricing and stronger margins.

Digital Health has become a pivotal growth engine for RadNet, as AI‑enabled tools improve workflow efficiency, reduce labor strain, and enhance diagnostic accuracy. The recent Gleamer acquisition, valued at up to €230 million, bolsters RadNet’s AI portfolio with an estimated $30 million in annual recurring revenue and $7 million in run‑rate synergies. Combined with DeepHealth, the expanded suite now supports over 75 clinical indications across more than 2,700 customers worldwide, reinforcing RadNet’s claim as the world’s largest provider of radiology AI solutions. This strategic push aligns with broader industry moves toward subscription‑based software models and recurring revenue streams.

Financially, RadNet maintains a disciplined capital structure, reporting a net debt‑to‑adjusted‑EBITDA ratio around 1.0 and a record‑low DSO of 29.5 days. Management’s 2026 outlook projects imaging‑center revenue growth of 17‑19% and Digital Health expansion of 45‑55%, driven by same‑center performance, tuck‑in acquisitions, and new FDA clearances. Free cash flow is expected to rise 29‑41%, supporting further investments while mitigating headwinds such as labor cost inflation and seasonal weather impacts. Investors are watching closely as RadNet leverages its AI capabilities to sustain margin expansion and capture a larger slice of the $30 billion radiology market.